State Board of Administration of Florida Retirement System’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,117
Closed -$828K 2430
2023
Q2
$828K Sell
8,117
-590
-7% -$55.8K ﹤0.01% 1298
2023
Q1
$792K Sell
8,707
-220
-2% -$12.9K ﹤0.01% 1340
2022
Q4
$339K Sell
8,927
-4,860
-35% -$167K ﹤0.01% 1794
2022
Q3
$346K Hold
13,787
﹤0.01% 1796
2022
Q2
$419K Buy
13,787
+800
+6% +$23.9K ﹤0.01% 1755
2022
Q1
$425K Hold
12,987
﹤0.01% 1868
2021
Q4
$342K Sell
12,987
-559
-4% -$43.3K ﹤0.01% 2000
2021
Q3
$1.36M Buy
13,546
+570
+4% +$66.8K ﹤0.01% 1261
2021
Q2
$1.84M Sell
12,976
-19,476
-60% -$2.2M ﹤0.01% 1125
2021
Q1
$3.23M Buy
32,452
+20
+0.1% +$2.33K 0.01% 976
2020
Q4
$4.01M Buy
32,432
+2,449
+8% +$322K 0.01% 917
2020
Q3
$2.92M Buy
29,983
+3,460
+13% +$432K 0.01% 930
2020
Q2
$4.14M Buy
26,523
+16,531
+165% +$2.51M 0.01% 850
2020
Q1
$1.44M Buy
9,992
+790
+9% +$153K ﹤0.01% 1049
2019
Q4
$1.88M Buy
9,202
+640
+7% +$117K ﹤0.01% 1078
2019
Q3
$687K Hold
8,562
﹤0.01% 1541
2019
Q2
$808K Buy
8,562
+660
+8% +$57K ﹤0.01% 1489
2019
Q1
$675K Buy
7,902
+290
+4% +$24.1K ﹤0.01% 1616
2018
Q4
$427K Buy
7,612
+686
+10% +$41.9K ﹤0.01% 1801
2018
Q3
$566K Hold
6,926
﹤0.01% 1804
2018
Q2
$242K Buy
+6,926
New +$211K ﹤0.01% 2196

Other funds holding RETA

State Board of Administration of Florida Retirement System's RETA Position: Q3 2023 in Review

State Board of Administration of Florida Retirement System sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 8,117 shares — an estimated $828K sold.

State Board of Administration of Florida Retirement System first reported a position in RETA in Q2 2018 and held it in 21 quarters. The position peaked at $4.14M in Q2 2020. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • State Board of Administration of Florida Retirement System reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 8,117 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $828K.
  • State Board of Administration of Florida Retirement System first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2018 and held it in 21 quarters.
  • State Board of Administration of Florida Retirement System's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $4.14M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q3 2023, filed 8 Nov 2023.